Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
2021 · EBioMedicine · 385 citations
https://doi.org/10.1016/j.ebiom.2021.103255
D
Danny Jonigk
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
614
Papers
16.2K
Citations
51
h-index
219
i10-index
Danny Jonigk is an academic researcher from Medizinische Hochschule Hannover. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Transplantation: Methods and Outcomes & Pulmonary Hypertension Research and Treatments. The author has an h-index of 51, co-authored 522 publications.
ORCID: 0000-0002-5251-2281Papers by this author
worksAnti-inflammatory and immunomodulatory properties of α1-antitrypsin without inhibition of elastase
2013 · Proceedings of the National Academy of Sciences · 252 citations
https://doi.org/10.1073/pnas.1309648110
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections
2018 · Nature Communications · 157 citations
https://doi.org/10.1038/s41467-018-07570-7
Genetically diverse Pseudomonas aeruginosa populations display similar transcriptomic profiles in a cystic fibrosis explanted lung
2019 · Nature Communications · 96 citations
https://doi.org/10.1038/s41467-019-11414-3
Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension
2020 · American Journal of Respiratory Cell and Molecular Biology · 76 citations
https://doi.org/10.1165/rcmb.2019-0431oc
Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality
2017 · Journal of Occupational Medicine and Toxicology · 73 citations
https://doi.org/10.1186/s12995-017-0158-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat